Suppr超能文献

使用 α-氨基脒合成新型 5,6,7,8-四氢喹唑啉衍生物及其生物活性的计算机筛选。

Synthesis of Novel Derivatives of 5,6,7,8-Tetrahydroquinazolines Using α-Aminoamidines and In Silico Screening of Their Biological Activity.

机构信息

Institute of Chemistry and School of Chemistry, V. N. Karazin Kharkiv National University, 4 Svobody Sq., 61022 Kharkiv, Ukraine.

State Scientific Institution "Institute for Single Crystals", National Academy of Sciences of Ukraine, 60 Nauky Ave, 61072 Kharkiv, Ukraine.

出版信息

Int J Mol Sci. 2022 Mar 29;23(7):3781. doi: 10.3390/ijms23073781.

Abstract

α-Aminoamidines are promising reagents for the synthesis of a diverse family of pyrimidine ring derivatives. Here, we demonstrate the use of α-aminoamidines for the synthesis of a new series of 5,6,7,8-tetrahydroquinazolines by their reaction with bis-benzylidene cyclohexanones. The reaction occurs in mild conditions and is characterized by excellent yields. It has easy workup, as compared to the existing methods of tetrahydroquinazoline preparation. Newly synthesized derivatives of 5,6,7,8-tetrahydroquinazoline bear protecting groups at the C2--butyl moiety of a quinazoline ring, which can be easily cleaved, opening up further opportunities for their functionalization. Moreover, molecular docking studies indicate that the synthesized compounds reveal high binding affinity toward some essential enzymes of , such as dihydrofolate reductase (DHFR), pantothenate kinase (PanK), and FAD-containing oxidoreductase DprE1 (DprE1), so that they may be promising candidates for the molecular design and the development of new antitubercular agents against multidrug-resistant strains of the . Finally, the high inhibition activity of the synthesized compounds was also predicted against β-glucosidase, suggesting a novel tetrahydroquinazoline scaffold for the treatment of diabetes.

摘要

α-氨基脒是合成各种嘧啶环衍生物的有前途的试剂。在这里,我们展示了α-氨基脒在温和条件下与双苄叉环己酮反应合成一系列新的 5,6,7,8-四氢喹唑啉的用途。与现有的四氢喹唑啉制备方法相比,该反应具有产率优异、操作简便等优点。新合成的 5,6,7,8-四氢喹唑啉衍生物在喹唑啉环的 C2-丁基部分带有保护基团,这些保护基团可以很容易地被切断,为它们的进一步官能化开辟了更多的机会。此外,分子对接研究表明,所合成的化合物对分枝杆菌的一些重要酶(如二氢叶酸还原酶(DHFR)、泛酸激酶(PanK)和含 FAD 的氧化还原酶 DprE1(DprE1))具有高结合亲和力,因此它们可能是针对耐多药分枝杆菌菌株的分子设计和新型抗结核药物开发的有前途的候选药物。最后,还预测了所合成的化合物对β-葡萄糖苷酶的高抑制活性,这表明了一种用于治疗糖尿病的新型四氢喹唑啉骨架。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b231/8999073/50e5e2d59233/ijms-23-03781-sch001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验